| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Activis/Allergan 1528114 | 13,183,762 | 13,183,750 |
| Stock Portfolio | 7,403,009 | 7,255,297 |
| Unrealized Loss on Portfolio | 172,846 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| Deferred Income on Investments | FMV | 1,462 | 1,462 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Legal Fees | 17,520 | 0 | 0 | 0 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Filing Fees | 1,170 | |||
| Other Costs | 13 | |||
| Outgoing Wire Charges | 25 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Other Investment Income | 9,255 | 9,255 |
| Description | Amount |
|---|---|
| Wash Sale Disallowed | 3,805 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| Due to Owners | 18,690 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Asset Mark Account Fees | 59,926 | 59,926 | 0 | 0 |
| Merrill Lynch Account Fees | 160 | 160 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Foreign Taxes | 638 | 638 |